HER2-positive metastatic breast cancer with brain metastases responds favorably to pyrotinib and trastuzumab-based treatment: A case report and literature review

HER2-positive metastatic breast cancer with brain metastases responds favorably to pyrotinib and trastuzumab-based treatment: A case report and literature review

For HER2-positive metastatic breast cancer patients with the brain involved at initial diagnosis, there was no standard regimen before 2022 when the HER2CLIMB trial published its final overall survival analysis, and the prognosis is relatively poor under the current treatment strategy. We herein rep...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: Min-long Chen, Wenjie Yu, Binbin Cui, Yijian Yu, Zhaosheng Ma
Materiálatiipa: Artihkal
Giella:English
Almmustuhtton: Frontiers Media S.A. 2023-01-01
Ráidu:Frontiers in Oncology
Fáttát:
breast cancer
brain metastase
pyrotinib
trastuzumab
treatment
Liŋkkat:https://www.frontiersin.org/articles/10.3389/fonc.2022.980635/full

Interneahtta

https://www.frontiersin.org/articles/10.3389/fonc.2022.980635/full

Geahča maid